Health-Related Quality of Life During Three Trimesters of Pregnancy in Morocco: Cross-Sectional Pilot Study

Speaker(s)

ABSTRACT WITHDRAWN

OBJECTIVES: Assessing the health-related quality of life (HRQoL) during pregnancy and its associated factors.

METHODS: In this cross-sectional pilot study carried out from August to December 2019 we assessed the HRQoL and its associated factors among Moroccan pregnant women who received prenatal care at Settats health centers. The collected data from 270 pregnant women were compared to a dataset of 289 non-pregnant women using the EQ-5D-5L instrument and socioeconomic and obstetrical questionnaires. A multiple linear regression model was used to identify associated factors. The HRQoL comparison was made using the improved RIDIT approach.

RESULTS: Our results showed that the HRQoL in pregnant women was significantly lower than in non-pregnant women (EQ-5D index score = 0.71 ± 0.24 vs 0.79 ± 0.29; p < 0.0001). Similarly, the pregnancy reduced the EQ-VAS score (mean difference = -7.8 ± 17.21; p < 0.0001). The pregnancy increased the problems in mobility (ARI = 9.7% [1.717.6], p = 0.02), in self-care (ARI = 8% [214], p = 0.01), and in usual activities (ARI = 27.3% [18.935.7], p < 0.0001). Also, the pregnancy increased pain/discomfort (ARI = 26.5% [1835.1], p < 0.0001) and anxiety/depression (ARI = 12% [3.220.9], p = 0.0112). The rural pregnant women had the worst HRQoL (EQ-5D index score = 0.57) compared to their urban peers (EQ-5D index score = 0.77). Likewise, women in the third trimester and nulliparous had the worst HRQoL (EQ-5D index score = 0.64 and 0.84 respectively).

CONCLUSIONS: The place of residence, parity, and gestational age are strongly associated with pregnants HRQoL. The five EQ-5D-5L dimensions were affected during pregnancy. Consequently, there is a need to develop specific programs to monitor the HRQoL during pregnancy in order to ensure better maternal health care.

Code

PCR261

Topic

Epidemiology & Public Health, Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes, Public Health

Disease

No Additional Disease & Conditions/Specialized Treatment Areas